Verily - Sanofi joint venture Onduo has signed a deal with GE Healthcare Technologies to offer the latter firm 's SurroSense Rx system to select users of Onduo ’s personalised diabetes management platform in 2019 . The system consists of a thin sensor that is placed in a patient’s shoes and a wirelessly connected smartwatch, which displays readings and alerts to the user when dangerous pressure levels are detected. Orpyx 's SurroSense Rx system comprises a thin sensor , which is placed inside a patient 's shoe , and sends an alert to a connected smartwatch if it detects dangerous pressure levels .
Verily - Sanofi joint venture Onduo has signed a deal with GE Healthcare Technologies to offer the latter firm 's SurroSense Rx system to select users of Onduo ’s personalised diabetes management platform in 2019 . Orpyx 's SurroSense Rx system comprises a thin sensor , which is placed inside a patient 's shoe , and sends an alert to a connected smartwatch if it detects dangerous pressure levels .